DiaMedica Therapeutics Inc. (DMAC)
NCM · Common · CUSIP 25253X207
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for DMAC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
25253X207
Market Cap
Small Cap
IPO
12/7/2018 · $4.00/share
Business: DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with a focus on neurological and kidney diseases.

Company Contact

CEO
Rick Pauls
CFO
Scott Kellen
Headquarters
301 Carlson Parkway, Suite 210, Minneapolis, MN 55305
Phone
763-496-5454
Fax
763-710-4456
Investor Relations
Scott Kellen · 763-710-4456 · skellen@diamedica.com
General Email
IR@diamedica.com
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »